Sökning: "genital herpes infection"
Visar resultat 1 - 5 av 18 avhandlingar innehållade orden genital herpes infection.
1. Development of novel immunization approaches to generate immunity in the female genital tract with special reference to genital herpesDetta är en avhandling från Göteborg : Göteborg University
Sammanfattning : Development of mucosal vaccines for inducing immunity in the female reproductive tract would have profound implications for the prevention of sexually transmitted diseases. Despite numerous efforts, no such vaccines are currently available for human use. LÄS MER
- Detta är en avhandling från Göteborg
Sammanfattning : Herpes simplex virus type 2 (HSV-2) is a sexually transmitted pathogen that infects the genital tract mucosa and is the most common case of genital ulcers in humans. Despite numerous studies, little is known about the mechanisms involved in immune protection and no anti-herpes vaccine has been developed to date. LÄS MER
3. Herpes simplex virus infection: epidemiological aspects and analysis of the type-specific antibody responseDetta är en avhandling från Göteborg : Göteborg University
Sammanfattning : Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are ubiquitous viruses, often leading to asymptomatic infections in humans. However, different clinical presentations can be seen including recurrent oral or genital lesions, meningitis and neonatal herpes. LÄS MER
- Detta är en avhandling från Göteborg : University of Gothenburg
Sammanfattning : Sexually transmitted infections (STIs) cause a socioeconomic burden, morbidity and even mortality in a large part of the human population all over the world today. One of the most common genital ulcerative diseases is caused by herpes simplex virus type 2 with over 536 million people infected world-wide. LÄS MER
5. Immunization approaches and molecular signatures for mucosal immunity to primary and recurrent genital herpesDetta är en avhandling från Göteborg : University of Gothenburg
Sammanfattning : Genital herpes is most commonly caused by herpes simplex virus type 2 (HSV-2), and is a prevalent sexually transmitted infection worldwide. Despite numerous efforts, there is currently no licensed vaccine against the disease. LÄS MER